ArticleCell reports2024
PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.
Chan D K Nguyen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it